Insider Transactions in Q1 2022 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,164
-3.11%
|
$87,444
$21.06 P/Share
|
|
Mar 15
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,123
-2.28%
|
$56,214
$18.94 P/Share
|
|
Mar 01
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,123
-2.23%
|
$59,337
$19.73 P/Share
|
|
Mar 01
2022
|
Ajay Madan Chief Development Officer |
BUY
Open market or private sale
|
Direct |
9,000
+4.84%
|
$171,000
$19.88 P/Share
|
|
Feb 28
2022
|
Alan Seth Krasner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,250
+38.71%
|
-
|
|
Feb 28
2022
|
Stephen F. Betz Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+10.54%
|
-
|
|
Feb 28
2022
|
Ajay Madan Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,950
+6.98%
|
-
|
|
Feb 28
2022
|
Marc Wilson CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+19.28%
|
-
|
|
Feb 28
2022
|
Jeff E. Knight Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,950
+50.0%
|
-
|
|
Feb 28
2022
|
Richard Scott Struthers President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,400
+48.19%
|
-
|
|
Feb 15
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,123
-2.46%
|
$56,214
$18.64 P/Share
|
|
Feb 07
2022
|
Ajay Madan Chief Development Officer |
SELL
Open market or private sale
|
Direct |
13,411
-7.23%
|
$227,987
$17.83 P/Share
|
|
Feb 01
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,123
-2.41%
|
$56,214
$18.79 P/Share
|
|
Jan 19
2022
|
Alan Seth Krasner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,700
-44.63%
|
$140,700
$21.21 P/Share
|
|
Jan 19
2022
|
Alan Seth Krasner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,700
+30.86%
|
$80,400
$12.01 P/Share
|
|
Jan 18
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,168
-3.13%
|
$95,864
$23.29 P/Share
|
|
Jan 03
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,168
-5.11%
|
$200,704
$28.02 P/Share
|